Evolution between hosts and their parasites is hypothesized to play a central role in several biological phenomena, including the maintenance of biodiversity (Haldane [1949](#evo12909-bib-0233){ref-type="ref"}) and virulence (Best et al. [2009](#evo12909-bib-0010){ref-type="ref"}). Host--parasite evolutionary interactions are largely studied in a pairwise species framework, both empirically across a wide range of experimental systems (e.g. King et al. [2009](#evo12909-bib-0041){ref-type="ref"}; Schulte et al. [2010](#evo12909-bib-0071){ref-type="ref"}; Thrall et al. [2012](#evo12909-bib-0077){ref-type="ref"}; Decaestecker et al. [2013](#evo12909-bib-0025){ref-type="ref"}; Duncan et al. [2013](#evo12909-bib-0026){ref-type="ref"}) and theoretically (Bell and Smith [1987](#evo12909-bib-0006){ref-type="ref"}; Kouyos et al. [2009](#evo12909-bib-0043){ref-type="ref"}). However, in nature, most host--parasite interactions will be driven within a network of ecological interactions. For example, coinfection of a host individual by a diversity of parasite species (Telfer et al. [2010](#evo12909-bib-0075){ref-type="ref"}) and competition between these parasites for host resources (Ulrich and Schmid‐Hempel [2012](#evo12909-bib-0079){ref-type="ref"}) are common. Evolutionary interactions between multiple parasites can also have important consequences for parasite transmission and virulence (Ben‐Ami et al. [2008](#evo12909-bib-0007){ref-type="ref"}; Balmer et al. [2009](#evo12909-bib-0002){ref-type="ref"}; Griffiths et al. [2011](#evo12909-bib-0031){ref-type="ref"}; Kwan and Ernst [2011](#evo12909-bib-0045){ref-type="ref"}). Introducing multiple parasite species into the standard host--parasite evolutionary framework may thus provide useful insights as to how evolution operates in natural host--parasite communities (Mitchell‐Olds and Bergelson [2000](#evo12909-bib-0055){ref-type="ref"}; Mostowy et al. [2010](#evo12909-bib-0057){ref-type="ref"}).

Here, we use experimental evolution to test for the effects of parasite diversity on host--parasite population dynamics and evolution using the bacterium *Pseudomonas aeruginosa* and its bacteriophages. *P. aeruginosa* is an opportunistic human pathogen. The strain used in these experiments (PAO1) was originally isolated from a burn wound infection from a patient in Melbourne (Holloway [1955](#evo12909-bib-0034){ref-type="ref"}). Contemporary strains of *P. aeruginosa* cause pneumonia in hospitals (Jones [2010](#evo12909-bib-0038){ref-type="ref"}) and in particular cause mortality in patients with cystic fibrosis (Behrends et al. [2013](#evo12909-bib-0005){ref-type="ref"}). Bacteriophages, the viral parasites of bacteria, are ideally suited to laboratory studies of evolution (Buckling et al. [2009](#evo12909-bib-0017){ref-type="ref"}). Bacteriophages are the most numerous form of life on the planet (Chibani‐Chennoufi et al. [2004](#evo12909-bib-0022){ref-type="ref"}). They are ecologically important as they are responsible for killing an estimated 50% of the total bacterial population on earth every 48 hours (Fischetti et al. [2006](#evo12909-bib-0028){ref-type="ref"}). Their ability to depress bacterial populations was recognized early in the 20^th^ century (D\'Herelle [1922](#evo12909-bib-0024){ref-type="ref"}) when they were used to treat many diseases including staphylococcal skin infections, dysentery, and the bubonic plague (Sulakvelidze et al. [2001](#evo12909-bib-0073){ref-type="ref"}).

Host resistance to bacteriophages can arise through mutation or reduced expression of the receptor molecule (Samson et al. [2013](#evo12909-bib-0066){ref-type="ref"}). Changes in gene expression can be coordinated by quorum sensing molecules that reduce the expression of a bacteriophage receptor in the whole bacterial population (Høyland‐Kroghsbo et al. [2013](#evo12909-bib-0035){ref-type="ref"}). Lysogenic bacteriophage are known to provide resistance against superinfection (Berngruber et al. [2010](#evo12909-bib-0009){ref-type="ref"}) and lytic phage may also be capable of excluding superinfection by their competitors. For example the pilus‐binding phage LUZ19 down regulates LPS genes in PAO1 upon infection (Lavigne et al. [2013](#evo12909-bib-0047){ref-type="ref"}), potentially reducing the ability of any LPS‐binding competitor phage from entering the same cell. However, resistance is not a binary trait: phages can infect and replicate within partially resistant cells without having a large impact on bacterial growth (Levin and Bull [2004](#evo12909-bib-0049){ref-type="ref"}).

Early investigations of phage‐bacteria evolution focused on single bacterial strains evolving with a single phage (Buckling and Rainey [2002](#evo12909-bib-0018){ref-type="ref"}; Mizoguchi et al. [2003](#evo12909-bib-0056){ref-type="ref"}; Brockhurst et al. [2007](#evo12909-bib-0016){ref-type="ref"}; Forde et al. [2008](#evo12909-bib-0029){ref-type="ref"}; Poullain et al. [2008](#evo12909-bib-0063){ref-type="ref"}). However, diverse phage communities exist in the human microbiome (Minot and Bryson [2013](#evo12909-bib-0054){ref-type="ref"}; Naidu et al. [2014](#evo12909-bib-0058){ref-type="ref"}; Liu et al. [2015](#evo12909-bib-0050){ref-type="ref"}), in the environment (Paul et al. [2002](#evo12909-bib-0061){ref-type="ref"}; Williamson et al. [2005](#evo12909-bib-0082){ref-type="ref"}), and are artificially assembled for phage therapy (Merabishvili et al. [2009](#evo12909-bib-0053){ref-type="ref"}; Chan et al. [2013](#evo12909-bib-0021){ref-type="ref"}). While one study showed that multiple phages can engage in within‐host competition giving an advantage to fast‐replicating phage (Refardt [2011](#evo12909-bib-0065){ref-type="ref"}), the presence of additional enemies (predators, parasites, or competitors) in the bacteria‐phage pairwise framework has been shown to affect host populations and their evolution. Adding a resistant bacterial competitor to a pairwise phage‐bacteria interaction resulted in greater suppression of bacterial growth, occasionally leading to host extinction, an observation not commonly made in bacterial monocultures (Harcombe and Bull [2005](#evo12909-bib-0033){ref-type="ref"}). Similarly, combining bacteriophage into three‐phage communities suppresses bacterial host growth more than the constituent phages can achieve alone (Turki et al. [2012](#evo12909-bib-0078){ref-type="ref"}). Multiple enemies may also shape the degree to which resistance is enemy specific in evolved host populations. For example combining the well‐studied *P. fluorescens* SBW25--Φ2 bacteriophage system with the predator, *Tetrahymena thermophila*, can select for divergent outcomes: either specialists, whereby hosts are good at resisting either the phage or predator (Friman and Buckling [2013](#evo12909-bib-0030){ref-type="ref"})---or for a population of generalists that can resist both (Örmälä‐Odegrip et al. [2015](#evo12909-bib-0060){ref-type="ref"}). Phage communities have also been shown to select for the same resistance specialist strategies as the single phage that make up the community rather than a generalist phenotype (Koskella et al. [2012](#evo12909-bib-0042){ref-type="ref"}).

In our study, we manipulated phage diversity by mixing all combinations of a panel of five naturally isolated lytic phages with their bacterial host, *P. aeruginosa* PAO1, and allowed them to evolve in response to those phage combinations. We predicted that, relative to phage monocultures, increasingly diverse phage communities would (i) reduce phage density due to more intense phage competition in communities, (ii) be more effective at suppressing host growth, (iii) favor general, and perhaps costly, resistance mechanisms, and thereby (iv) reduce selection for resistance to phages. We found that diverse phage communities initially acted synergistically and reduced bacterial host population growth within the first three hours of interaction. This synergy between phages eventually transitioned into antagonism as phage community size reduced and host populations recovered most efficiently in diverse phage communities. Host populations rapidly evolved resistance across all phage community treatments, a finding confirmed by whole‐genome sequencing, with more generalized resistance mechanisms selected for by the five‐phage community and specific resistance to phage receptors evolving against phage monocultures. Finally, we found that resistance evolved as rapidly against a diversity of parasites as against a single parasite species, all within 24 hours. Our results indicate that diverse parasite communities shape host and parasite population dynamics and evolutionary responses. We further discuss the implications of our results for applying a diversity of phages as biological control agents.

Materials and Methods {#evo12909-sec-0020}
=====================

STRAINS, STORAGE, AND CULTURE CONDITIONS {#evo12909-sec-0030}
----------------------------------------

*P. aeruginosa PAO1* was used with a panel of five, field‐isolated, lytic bacteriophage; PEV2, LMA2, 14/1, LUZ7, and LUZ19. These phages have previously been used separately in evolution experiments with *P. aeruginosa*, making them ideally suited for combination into experimental communities. LUZ19 is believed to rely on type IV pili for attachment (Chibeu et al. [2009](#evo12909-bib-0023){ref-type="ref"}; Lammens et al. [2009](#evo12909-bib-0046){ref-type="ref"}). The receptors for PEV2 and LUZ7 (classified as N4‐like phages) are unknown, however in order to attach to their hosts, these phages may rely on either LPS (Ceyssens et al. [2009b](#evo12909-bib-0020){ref-type="ref"}) or NrfA (Kiino and Rothman‐denes [1989](#evo12909-bib-0039){ref-type="ref"}), a membrane protein with homology to TadD (McPartland [2008](#evo12909-bib-0052){ref-type="ref"}) that is involved type IV pili formation (Bernard et al. [2009](#evo12909-bib-0008){ref-type="ref"}). LMA2 and 14/1 are related to PB1 (Ceyssens et al. [2009a](#evo12909-bib-0019){ref-type="ref"}) that relies on LPS for attachment (Kropinski et al. [1977](#evo12909-bib-0044){ref-type="ref"}). Isogenic bacterial stocks were prepared by inoculating 15 mL tubes containing 3 mL King\'s B (KB) medium (King et al. [1954](#evo12909-bib-0040){ref-type="ref"}) with twice streaked bacterial colonies from a frozen (--80°C) stock. The tubes were incubated in a MaxQ 8000 (Thermo Scientific, Waltham, MA, USA) at 225RPM for 24 hours at 37°C. In the absence of phage but otherwise the condition of this experiment, this would allow for 4--5 bacterial doublings before stationary phase but the lysis caused by phage makes accurate estimation of doubling time almost impossible. Previous work with these phages has shown that 24 hours is sufficient for considerable phenotypic change (Betts et al. [2013](#evo12909-bib-0012){ref-type="ref"}, [2014](#evo12909-bib-0011){ref-type="ref"}).

Bacteriophages were purified from bacteria by using 0.1 vol. chloroform and centrifugation at 13,000 *g* to kill and pellet the bacteria. Working bacteriophage stocks were prepared from frozen isogenic aliquots; a 1 μL loop was used to inoculate a 3 mL bacterial suspension (OD~600~ = 0.3). This was incubated for 24 hours at 225 RPM and 37°C before purification and filtration using a 0.22 μm syringe filter. The filtrates were diluted in M9 buffer to 1 × 10^8^ plaque forming units (PFU) mL^−1^ and stored at +4°C for experimental use.

EXPERIMENTAL DESIGN {#evo12909-sec-0040}
-------------------

All combinations of the five phages (one, two, three, four, and five‐phage communities) were prepared such that the phages were at 5 × 10^5^ PFU mL^−1^. Mixed phage communities were prepared to a final titre of 5 × 10^5^ PFU mL^−1^ with each phage present at equal densities. These phages were then mixed with fresh, diluted overnight culture in KB. Each overnight culture was prepared from a separate colony and used to inoculate each replicate to a starting concentration of 5 × 10^7^ colony forming units per mL (CFU mL^−1^). These mixtures were added to 96‐well plates, 200 μL per well, until there were six replicates of every possible phage combination and a phage‐free control (where the phage stock was substituted for M9 buffer). The six replicates were split evenly across two plates and incubated at 37°C for 24 hours.

MEASURING PHAGE GROWTH {#evo12909-sec-0050}
----------------------

Phage population size was measured at the end of the experiment for every treatment by counting plaque forming units (PFU), which provides a measure of viron density, using a soft agar overlay method (e.g., Buckling and Rainey [2002](#evo12909-bib-0018){ref-type="ref"}).

MEASURING BACTERIAL GROWTH {#evo12909-sec-0060}
--------------------------

The experiment was conducted in a Synergy 2 plate reader (BioTek Instruments, Winooski, VT, USA). OD~600~ was measured every 2.5 minutes for the duration of the 24‐hour experiment. All populations were then frozen at --80°C. Endpoint CFU counts were also performed.

MEASURING RESISTANCE {#evo12909-sec-0070}
--------------------

Evolved populations were streaked out on KB agar and incubated overnight at 37°C in a static incubator to present single colonies. These colonies were picked, streaked out for a second time, and similarly incubated to present single colonies. This process ensured that each colony was both isogenic and free of phage. Populations evolved with a single phage type were sampled by taking eight colonies each from the 12 populations (two populations per phage type, one from each plate). Six colonies were sampled from each of the 20 populations that evolved with three‐phage types (two populations per phage combination, one from each plate). The populations evolved with five‐phage types and the phage‐free controls were sampled by taking six from all six replicates of each.

These bacterial colonies were separately incubated for 24 hours in 5 mL tubes containing 3 mL KB. Then 100 μL from each tube was mixed separately with 2.9 mL of soft (0.75%) KB agar and poured over the surface of a (1.5%) KB agar plate. Separate 4 μL droplets of purified phage were then applied to this soft agar lawn, allowed to dry, and incubated for 24 hours, subsequently assessed for zones of inhibition to indicate susceptibility or resistance. Zones with no visible inhibition were scored as resistant ( = 1), with some visible inhibition were scored as partially resistant ( = 0.5), and with complete inhibition were scored as susceptible ( = 0). These data were then analyzed as the proportion of clones that were resistant or susceptible to a given phage isolate.

WHOLE GENOME SEQUENCING OF EVOLVED BACTERIA {#evo12909-sec-0080}
-------------------------------------------

A subsample of the twice‐streaked bacterial colonies scored for resistance were grown in 3 ml KB in a 5‐ml tube overnight at 37°C to provide the starting material for the extraction process. DNA was extracted from 1 ml of culture using a Dneasy Blood and Tissue kit (Qiagen, Inc., Chatworth, California, USA), quantified using the QuantiFluor dsDNA system (Promega, Madison, WI, USA) and the salt ratio verified by Nano Drop (Thermo Scientific, Waltham, MA, USA). Library preparation and sequencing was performed at the Wellcome Trust Centre for Human Genetics (Oxford, UK) on an Illumina MiSeq in a 2 × 300 paired end reaction using v3 reagents.

In total, an ancestral clone and 17 evolved clones were sequenced: six phage‐free evolved clones (one from each replicate) from 24 hours to control for possible laboratory adaptation, one from each replicate of the five‐phage treatment and one from the first replicate of each one‐phage population. The sequenced clones were randomly selected from those also scored for resistance. Full details of the bioinformatics are provided in the supplementary materials.

STATISTICAL ANALYSIS {#evo12909-sec-0090}
--------------------

Analysis and graphing was performed using JMP 10.0 (SAS Institute Inc. [2012](#evo12909-bib-0067){ref-type="ref"}). All data were analyzed using ANOVA without transformation. All post‐hoc contrasts were *t*‐tests with a significance threshold of 0.05. Between‐treatment final phage population size significance was analyzed by ANOVA. The OD~600~ data were analyzed by calculating the area under the curve using the trapz function within pracma in R 3.1.1 (R Core Team [2013](#evo12909-bib-0064){ref-type="ref"}), and then ANOVA where the same model was used on two subsets of the data; 0--3 hours and 21--24 hours. These time windows captured the initial suppression of host growth and the recovery of host populations where growth of resistant mutants had exceeded the maximum reached before the populations were suppressed. For the PFU data and the OD~600~ data, the number of phage types in the community was treated as a categorical explanatory variable. The resistance of bacteria evolved with single, three, and the five‐phage communities to the five ancestral phages were compared in two separate ANOVA tests. The resistance of evolved bacteria was compared to their sympatric ancestral phage, then to all five phage types, both allopatric and sympatric.

Results {#evo12909-sec-0100}
=======

EFFECTS OF PHAGE DIVERSITY ON BACTERIAL GROWTH {#evo12909-sec-0110}
----------------------------------------------

To measure the impact of phage diversity on bacterial population dynamics, we measured the optical density of bacterial populations that were exposed to phage relative to phage‐free control populations (0--3 h: F**~1,191~** = 18.4 *P* \< 0.01; 21--24 h: F**~1,191~** = 32.2 *P* \< 0.01). There was a significant effect of the number of phages both in early and late growth (0--3 h: F**~4,191~** = 6.6 *P* \< 0.01; 21--24 h: F**~4,191~** = 8.3 *P* \< 0.01) however the relationship between the number of phage and bacterial growth differed between the two time points (Fig. [1](#evo12909-fig-0001){ref-type="fig"}). In early growth (0--3 h), higher phage diversity was associated with a greater depression of bacterial population growth. Post‐hoc contrasts revealed that bacterial growth was suppressed significantly more by the four‐ and five‐phage treatments, which were not significantly different from one another. The three‐phage treatment was the next lowest, but the one and two‐phage treatments did not significantly differ. Conversely, in late growth (21--24 h), lower phage diversity was associated with a greater depression of bacterial population growth. The one‐phage treatment reduced bacterial growth more significantly than all other treatments, followed by the two‐phage treatment. The three‐, four‐, and five‐phage treatments did not significantly differ from one another. To confirm that optical density provides an appropriate measure of population density, we performed endpoint CFU counts, which corroborated the OD data (Fig. S1).

![(A) Shows the bacterial biomass concentration (OD~600~) over time for the different phage containing treatments and the phage‐free control. The areas under the curves for OD~600~ during the first 3 (B) and last 3 (C) hours of growth split by the number of phage types in the community. The area under the curve reflects how much bacterial biomass was present within the time window. Error bars show 1 standard error.](EVO-70-969-g001){#evo12909-fig-0001}

EFFECTS OF PHAGE DIVERSITY ON PHAGE GROWTH {#evo12909-sec-0120}
------------------------------------------

Although increasing phage diversity has the potential to increase bacterial mortality rates, increasing phage diversity also introduces the possibility for competition between phage types. To test for this effect, we measured the final phage titres (PFU ml^−1^) after 24 hours incubation (Fig. [2](#evo12909-fig-0002){ref-type="fig"}). There was a significant effect of phage community diversity on phage titer (F~4,180~ = 4.17, *P* \< 0.01). Post‐hoc contrasts revealed that the single‐phage treatment had the highest mean titer, while all other phage communities were lower and not significantly different from each other.

![Shows the mean phage titers measured after 24 hours where five bacteriophages were cultured in every possible combination up to a five‐phage community. There were six replicates of each possible combination split across two 96‐well plates. Error bars show one standard error.](EVO-70-969-g002){#evo12909-fig-0002}

EFFECTS ON BACTERIAL RESISTANCE EVOLUTION {#evo12909-sec-0130}
-----------------------------------------

Predation by phage generates selection for phage resistance in bacterial populations; increasing phage diversity is predicted to alter both the rate and mechanisms of resistance evolution. To test for resistance evolution, we measured the ability of the five ancestral phage to infect bacterial clones that were sampled from the end of our experiment. We found phenotypic resistance across all treatments and not the phage‐free control.

Firstly, we hypothesized that increasing phage diversity should decrease the rate of resistance evolution to sympatric phage (Fig. [3](#evo12909-fig-0003){ref-type="fig"}). There was a significant effect of phage community diversity (single‐, three‐, or five‐phage types) on mean resistance to sympatric phage (F**~2,605~** = 80.2.58 *P* \< 0.001). However, host resistance to the five ancestral phage types differed significantly (F**~4,605~** = 73.8 *P* \< 0.001) and resistance to the ancestral phages differed depending on treatment(F**~8,605~** = 12.65 *P* \< 0.001).

![Shows the mean bacterial resistance to the five ancestral phage types for those that had evolved with one, three and five phage types, Only sympatric data are included, that is only bacteria evolved with PEV2 were scored against PEV2. Error bars show 1 standard error.](EVO-70-969-g003){#evo12909-fig-0003}

The post‐hoc comparisons (*t*‐tests with a significance threshold of 0.05) revealed groupings among the five phage types. The degree of resistance in bacteria evolved against 14/1 and PEV2 differed from all others, but were not significantly different from each other. A similar pattern was revealed for bacterial populations evolved against LUZ7 and LMA2. In contrast, the degree of resistance in bacterial populations evolved against LUZ19 was significantly different from populations evolved against other phages. Within each phage type, the post‐hoc contrasts revealed a significant difference between evolved bacterial resistance among the phage communities, except for those evolved against PEV2 and 14/1 where the one and three phage populations did not differ.

Secondly, we hypothesized that parasite diversity would select for more generalized resistance mechanisms. We compared the resistance of the evolved bacteria from the single‐phage treatments to all five ancestral phages (Fig. [4](#evo12909-fig-0004){ref-type="fig"}). Here evolved bacterial isolates from the single, three, and five‐phage populations were exposed to all five phage types. The number of phage types with which bacteria had evolved significantly affected the mean resistance against the five phage types (F**~2,1164~** = 52.6 *P* \< 0.001). Nested within the single‐phage populations, the different phage types evolved with selected for different levels of resistance to allopatric phage (F**~13,1164~** = 4.48 *P* \< 0.001). Post‐hoc contrasts revealed similar groupings among the single‐phage populations. Populations evolved with 14/1 and PEV2 had selected for the highest resistance against the five ancestral phage, and were significantly different from all others, but not from each other. Similarly, LUZ19, LMA2, and LUZ7 had selected for the lowest resistance to the five ancestral phage, but did not differ from each other

![Shows the resistance of evolved bacteria averaged across the five different ancestral phage types against which they were challenged. The data are shown separately for the bacterial populations evolved with one, three and five phages in a single community. Error bars shows 1 standard error.](EVO-70-969-g004){#evo12909-fig-0004}

To confirm that the observed changes in resistance were due to evolution and not phenotypic plasticity, we sequenced bacterial clones to look for evidence of genomic changes. All of the evolved clones possessed a single chromosomal mutation relative to the ancestor revealing that genomic evolution had occurred within 24 hours. No mutations were observed in the clones sequenced from the phage‐free control populations. We observed parallel evolution in genes known to play roles in phage/bacteria interactions (e.g. LPS production). The details are summarized in Table [1](#evo12909-tbl-0001){ref-type="table-wrap"}.

###### 

Shows the mutations detected in the evolved bacteria

                        MUTATION INFORMATION   PHAGE RESISTANCE                                                                                              
  ------------ -------- ---------------------- ------------------ --------------- -------------------------------------------------- ----- ----- ----- ----- -----
  ONE‐PHAGE    PEV2     PA1959‐PA2216          --                 257 genes       mgd                                                0.5   0.5   0     0.5   0.5
               14/1     PA3154                 wzy                LPS             G94[\*](#evo12909-tbl1-note-0001){ref-type="fn"}   0.5   0     0     0.5   0.5
               LUZ7     PA2911                 --                 TonB receptor   L20P                                               0     0.5   0     0.5   0
               LMA2     PA2911                 --                 TonB receptor   A26fs                                              0     0.5   0     0.5   0
               LUZ19    PA3805                 pilF               Type IV pili    R169_L170insRL                                     0     0     1     0     0
  FIVE‐PHAGE   PA3154   wzy                    LPS                W207fs          1                                                  0     1     0     1     
                        PA3154                 wzy                LPS             A43Lfs                                             1     0     1     0     1
                        PA3154                 wzy                LPS             A43Lfs                                             1     0     1     0     1
                        PA0938                 wzz2               LPS             T263M                                              1     0     1     0     1
                        PA1893‐PA2206          --                 314 genes       mgd                                                0.5   0.5   0     0.5   0.5
                        PA0763                 mucA               Alginate        Q192fs                                             1     1     0.5   1     0.5

Each row shows the result for a single evolved clone. No mutations were detected in the phage‐free lines but a single mutation was detected in every phage‐evolved clones, one clone for each single‐phage treatment and 6 clones from the five‐phage treatment (fs--frameshift, mgd--multi‐gene deletion, \*--stop codon). The resistance of sequenced clones to the five ancestral phage types are also given. Clones were scored as either completely resistant ( = 1), partially resistant ( = 0.5), or completely susceptible ( = 0).
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Discussion {#evo12909-sec-0140}
==========

Here, we show that phage diversity drives significant changes in bacterial host ecology and evolution. While bacterial populations are initially depressed in size when exposed to a diversity of phages, they recover rapidly thereafter within a few hours. Recovery is likely due to a combination of resistance evolution and competition‐induced lower phage population sizes. The greater the phage diversity in the community, the more rapidly the hosts were initially suppressed suggesting an additive effect of phages on the host population. For example, mixed phage infections can result in increased infection success if one phage affects the host in such a way that it is then more susceptible to a second phage (Schmerer et al. [2014](#evo12909-bib-0069){ref-type="ref"}).

Conversely, after less than 24 hours this synergy gave way to antagonism between phages as phage diversity resulted in a lower phage population size, enhancing bacterial recovery. Competition between phages could take place both between and within hosts. Phages of the same type could compete over attachment sites on the host cell surface (Lenski [1988](#evo12909-bib-0048){ref-type="ref"}) or modify host gene expression to prevent other phages from attaching to the same cell (Pedruzzi et al. [1998](#evo12909-bib-0062){ref-type="ref"}). Additionally, when there is multiple‐infection, host death can occur prematurely, without phage production, as a result of damage caused by the sheer number of penetrations (Abedon [2011](#evo12909-bib-0001){ref-type="ref"}) thereby reducing both bacterial and phage population sizes. On the other hand, competition within the host could arise when phages differ in lysis time (Refardt [2011](#evo12909-bib-0065){ref-type="ref"}), and the slower phage fails to complete its life cycle. Such competition is important for bacteriophage ecology and can drive inter‐phage coevolutionary arms races (Wichman et al. [2005](#evo12909-bib-0081){ref-type="ref"}).

The increased recovery of bacterial populations evolving with the five‐phage communities could also be due to early bottlenecking. Strong initial selection for resistant clones left them to grow with little competition, consequently by 24 hours they had reached a higher biomass concentration than the other treatments. Interestingly, the greater bacterial recovery observed in bacterial populations evolving with the five‐phage communities relative to the single‐phage populations suggests that despite the diversity of parasites, the evolution of resistance was not delayed. A diversity of phages instead applied a stronger selection pressure and allowed for greater bacterial recovery. Parasite competition affects the dynamics of infection in other systems (Hughes et al. [2004](#evo12909-bib-0036){ref-type="ref"}; Ulrich and Schmid‐Hempel [2012](#evo12909-bib-0079){ref-type="ref"}) but interactions between parasites can also lead to more virulent infections, for example in the case of HIV enhancing the TB epidemic (Kwan and Ernst [2011](#evo12909-bib-0045){ref-type="ref"}).

Our results are consistent with the hypothesis that hosts evolving with a diverse parasite assemblage are more likely to evolve generalized resistance mechanisms, while pairwise evolution selects for specific resistance (Thrall et al. [2007](#evo12909-bib-0076){ref-type="ref"}). For example, a single mutation in *pilF* (involved in type IV pili formation) occurred in the bacterial population that evolved with LUZ19 (which is type IV pili‐dependent phage). This mutation conferred complete resistance to LUZ19 and did not occur in any of the sampled bacterial populations subjected to attack by five‐phage communities (Table [1](#evo12909-tbl-0001){ref-type="table-wrap"}). However, a single mutation in *mucA* was observed that seemed to confer partial resistance to multiple phage types. MucA represses alginate production and its inactivation is associated with conversion to mucoidy (Boucher et al. [1997](#evo12909-bib-0014){ref-type="ref"}). Mucoid phenotypes have been shown to evolve in response to bacteriophage selection pressure in other systems (Vogwill et al. [2011](#evo12909-bib-0080){ref-type="ref"}; Tazzyman and Hall [2014](#evo12909-bib-0074){ref-type="ref"}), but such a mutation was not present here in the single‐phage treatments. These data will enable the formation of more developed hypotheses in our future work.

When evolved bacterial populations from all treatments were tested against all five ancestral phage, we observed the greatest breadth of resistance in those populations that had evolved with all five‐phage types. This result suggests that the greater the phage diversity, the more bacterial populations are likely to evolve a broad resistance phenotype. When we focus on sympatric bacteria‐phage comparisons only, we observe a strong phage‐dependent effect such that for PEV2 and 14/1 combination into five‐phage communities increases the amount of resistance evolved to these phage whereas the amount of resistance to LUZ7, LMA2, and LUZ19 decreases when they are combined with other phage. Interestingly, for all phage the level of evolved resistance was always lower for the three‐phage communities than the five‐phage communities, suggesting that there are important interactions between phages when in communities, perhaps in the form of competition for hosts (as suggested by the observed reduction in phage population size in communities) and evolution of cross‐resistance (Fig. S2).

Future work will need to establish the effects of combining phage types on longer term host--parasite coevolutionary dynamics. Here, we show widespread evolution of resistance, but our data also indicate that a degree of partial susceptibility remained. Thus, it is possible that some individuals at lower frequency remained completely susceptible (Schrag and Mittler [1996](#evo12909-bib-0070){ref-type="ref"}; Bohannan and Lenski [2000](#evo12909-bib-0013){ref-type="ref"}), providing the host reservoirs necessary for coevolution with phages. All the phages herein have been shown to exhibit the ability to coevolve with *P. aeruginosa* (Betts et al. [2014](#evo12909-bib-0011){ref-type="ref"}), and the nature of host mutations observed has interesting implications for potential long‐term coevolutionary dynamics with bacteriophage communities. When coevolution was restricted to pairwise interactions in this study, mutations occurred at different loci depending on the phage type. For instance, two out of five clones showed LPS mutations with the remaining three in either type IV pili‐ or TonB‐dependent receptors. In contrast, five out of six clones from bacteria populations evolved with the five‐phage communities had mutations in LPS, and one additional mucoidy‐associated mutation. When different LPS phages were combined, they can coselect for the same resistance mechanism. The LPS phages PEV2 and 14/1 both selected for genes that effect LPS production and the five‐phage cocktail selected for similar mutations. Alternatively, there may be no genetic correlation in resistance to LPS phage and type IV pili; specific resistance to LUZ19 (type IV pili dependent) via a single mutation in a pili gene confers no protection to any of the other phage and so combining them might allow for diffuse coevolution. A mixture of diffuse and pairwise coevolution may take place when host populations coevolve with a diverse parasite community (Brockhurst et al. [2014](#evo12909-bib-0015){ref-type="ref"}).

There are implications in our results for the application of a "cocktail" of phage types to treat bacterial infections. In phage therapy, phages may be administered as monocultures (Skurnik and Strauch [2006](#evo12909-bib-0072){ref-type="ref"}) or in multiphage communities (Chan et al. [2013](#evo12909-bib-0021){ref-type="ref"}). The single phage has the advantage of simpler kinetics and less regulatory burden (Lu and Koeris [2011](#evo12909-bib-0051){ref-type="ref"}), but it is limited by its host range (Hyman and Abedon [2010](#evo12909-bib-0037){ref-type="ref"}) and may only be effective against a narrow range of pathogen genotypes (Scanlan et al. [2013](#evo12909-bib-0068){ref-type="ref"}). However, the phage cocktail community can have a broader host range (Gu et al. [2012](#evo12909-bib-0032){ref-type="ref"}) and may delay the evolution of host resistance (Barbosa et al. [2013](#evo12909-bib-0003){ref-type="ref"}; Fischer et al. [2013](#evo12909-bib-0027){ref-type="ref"}). In addition to phage diversity, the phage titers are also important (Nilsson [2014](#evo12909-bib-0059){ref-type="ref"}) as phage therapy is more effective with greater multiplicity of infection (Beeton et al. [2015](#evo12909-bib-0004){ref-type="ref"}). Although our experiments were conducted in vitro and with a strain that is genetically divergent from those of current clinical relevance, they are novel in exposing bacteria to all phage types separately and simultaneously, for a clinically relevant period of time and for considering the effects on phage productivity. We observed that diverse phage communities did not delay the evolution of host resistance and eventually resulted in reduced phage titers. Our data thus suggest that boosting phage diversity in a cocktail might not automatically increase the efficacy of phage therapy.

In summary, we demonstrate that diverse parasite communities comprised of multiple phage types more rapidly depress host growth than the constituent phages alone and that increasing phage diversity did not delay the evolution of resistance. Our results therefore support the hypothesis that diverse parasite communities can impose stronger selection on host populations than single parasite species. Host resistance evolution also depends on the biology of individual parasite species in the community. Overall, our results demonstrate the potential for interesting ecological and evolutionary dynamics in bacteria‐phage communities beyond lab investigations of pairwise phage--host interactions. Exploring the effect of parasite community diversity will therefore be a significant step toward creating host--parasite coevolutionary mosaics (King et al. [2009](#evo12909-bib-0041){ref-type="ref"}; Thrall et al. [2012](#evo12909-bib-0077){ref-type="ref"}) more representative of nature and testing hypotheses on host--parasite coevolution in a community context.
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**Figure S1**: This figure shows the final bacterial population density measured by counting CFU per ML.
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Click here for additional data file.

###### 

**Figure S2**: Demonstrates the evolution of cross resistance to multiple phage following exposure to a single phage.

###### 

Click here for additional data file.
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